CML: BCR-ABL Mutation Diagnostics and their Importance for the daily Treatment

被引：0

作者：

不详

机构：

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷 / 06期

关键词：

CHRONIC MYELOID-LEUKEMIA; RESISTANCE; THERAPY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：416 / 416

页数：1

相关论文

共 5 条

[1] European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 [J].

Baccarani, Michele ;

Deininger, Michael W. ;

Rosti, Gianantonio ;

Hochhaus, Andreas ;

Soverini, Simona ;

Apperley, Jane F. ;

Cervantes, Francisco ;

Clark, Richard E. ;

Cortes, Jorge E. ;

Guilhot, Francois ;

Hjorth-Hansen, Henrik ;

Hughes, Timothy P. ;

Kantarjian, Hagop M. ;

Kim, Dong-Wook ;

Larson, Richard A. ;

Lipton, Jeffrey H. ;

Mahon, Francois-Xavier ;

Martinelli, Giovanni ;

Mayer, Jiri ;

Mueller, Martin C. ;

Niederwieser, Dietger ;

Pane, Fabrizio ;

Radich, Jerald P. ;

Rousselot, Philippe ;

Saglio, Giuseppe ;

Saussele, Susanne ;

Schiffer, Charles ;

Silver, Richard ;

Simonsson, Bengt ;

Steegmann, Juan-Luis ;

Goldman, John M. ;

Hehlmann, Ruediger .

BLOOD, 2013, 122 (06) :872-884

[2] Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency [J].

Shah, Neil P. ;

Skaggs, Brian J. ;

Branford, Susan ;

Hughes, Timothy P. ;

Nicoll, John M. ;

Paquette, Ronald L. ;

Sawyers, Charles L. .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09) :2562-2569

[3] Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy [J].

Soverini, Simona ;

Mancini, Manuela ;

Bavaro, Luana ;

Cavo, Michele ;

Martinelli, Giovanni .

MOLECULAR CANCER, 2018, 17

[4] Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors [J].

Soverini, Simona ;

Gnani, Alessandra ;

Colarossi, Sabrina ;

Castagnetti, Fausto ;

Abruzzese, Elisabetta ;

Paolini, Stefania ;

Merante, Serena ;

Orlandi, Ester ;

de Matteis, Silvia ;

Gozzini, Antonella ;

Iacobucci, Ilaria ;

Palandri, Francesca ;

Gugliotta, Gabriele ;

Papayannidis, Cristina ;

Poerio, Angela ;

Amabile, Marilina ;

Cilloni, Daniela ;

Rosti, Gianantonio ;

Baccarani, Michele ;

Martinelli, Giovanni .

BLOOD, 2009, 114 (10) :2168-2171

[5] BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia [J].

Zabriskie, Matthew S. ;

Eide, Christopher A. ;

Tantravahi, Srinivas K. ;

Vellore, Nadeem A. ;

Estrada, Johanna ;

Nicolini, Franck E. ;

Khoury, Hanna J. ;

Larson, Richard A. ;

Konopleva, Marina ;

Cortes, Jorge E. ;

Kantarjian, Hagop ;

Jabbour, Elias J. ;

Kornblau, Steven M. ;

Lipton, Jeffrey H. ;

Rea, Delphine ;

Stenke, Leif ;

Barbany, Gisela ;

Lange, Thoralf ;

Hernandez-Boluda, Juan-Carlos ;

Ossenkoppele, Gert J. ;

Press, Richard D. ;

Chuah, Charles ;

Goldberg, Stuart L. ;

Wetzler, Meir ;

Mahon, Francois-Xavier ;

Etienne, Gabriel ;

Baccarani, Michele ;

Soverini, Simona ;

Rosti, Gianantonio ;

Rousselot, Philippe ;

Friedman, Ran ;

Deininger, Marie ;

Reynolds, Kimberly R. ;

Heaton, William L. ;

Eiring, Anna M. ;

Pomicter, Anthony D. ;

Khorashad, Jamshid S. ;

Kelley, Todd W. ;

Baron, Riccardo ;

Druker, Brian J. ;

Deininger, Michael W. ;

O'Hare, Thomas .

CANCER CELL, 2014, 26 (03) :428-442